Risk factors for RDS in preterm newborns

  • Massimo Luerti
  • Giulio Bevilacqua
  • Alberto Agarossi
  • Maurizio Rocchetti
Chapter

Abstract

The prediction of RDS in preterm newborn, when the production of surfactant has not been measured, is based only on a certain fact: the incidence of the pathology progressively decreases when the gestational age increases. A series of factors, like the premature rupture of the membranes (ROM), maternal hypertension or diabetes, smoking, alcohol abuse or drug addiction, intrauterine growth retardation (IUGR), multiple pregnancy and neonatal condition at birth, are considered to affect the risk of developing the respiratory pathology, but the results obtained by different authors are not unequivocal [1–15].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Worthington, D. and Smith, B. T. Relation of amniotic fluid lecithin/ sphingomyelin ratio and fetal asphyxia to respiratory distress syndrome in premature infants. Can Med Assoc J 1978; 118: 1384.Google Scholar
  2. [2]
    Merritt, T. A. and Farrell, P. M. Diminished pulmonary lecithin synthesis in acidosis: experimental findings as related to the respiratory distress syndrome. Pediatrics 1976; 57: 32.Google Scholar
  3. [3]
    Cohen, M. M., Weintraub, D. H. and Lilienfeld, A. M. The relationship of pulmonary hyaline membrane to certain factors in pregnancy and delivery. Pediatrics 1960; 26: 42.Google Scholar
  4. [4]
    Yoon, J. J., Kohl, S. and Harper, R. G. The relationship between maternal hypertensive disease of pregnancy and the incidence of idiopathic respiratory distress syndrome. Pediatrics 1980; 65: 735.Google Scholar
  5. [5]
    Papageorgiou, A. N., Colle, E., Farri-Kostopoulos, E., et al. Incidence of respiratory distress syndrome following antenatal betamethasone. Pediatrics 1981; 67: 614.Google Scholar
  6. [6]
    Yoon, J. J. and Harper, R. G. Observations on the relationship between duration of rupture of the membranes and the development of idiopathic respiratory distress syndrome. Pediatrics 1973; 52: 161.Google Scholar
  7. [7]
    Bauer, C., Stern, L. and Colle, E. Prolonged rupture of membranes associated with a decreased incidence of respiratory distress syndrome. Pediatrics 1974; 53: 7.Google Scholar
  8. [8]
    Thibeault, D. W. and Emmanouillides, G. C. Prolonged rupture of fetal membranes and decreased frequency of respiratory distress syndrome and patent ductus arteriosus in preterm infants. Am J Obstet, Gynecol 1977; 131: 143.Google Scholar
  9. [9]
    Berkowitz, R. L., Kantor, R. D., Beck, G. J. and Warshaw, J. E. The relationship between premature rupture of the membranes and the respiratory distress syndrome. Am J Obstet Gynecol 1978; 131: 503.Google Scholar
  10. [10]
    White, E., Shy, K. K. and Benedetti, T. Chronic fetal stress and the risk of infant respiratory distress syndrome. Obstet, Gynecol 1986; 67: 57.Google Scholar
  11. [11]
    Morales, W. J., Diebel, N. D., Lazar, A. J. et al. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestation with premature rupture of membranes. Am J Obstet Gynecol 1986; 154: 591.CrossRefGoogle Scholar
  12. [12]
    Rokoa, J., Vaensorn, O., Nachman, R., et al. Hyaline membrane disease in twins. Pediatrics 1968; 42: 204–5.Google Scholar
  13. [13]
    Pender, C. B. Respiratory distress in multiple births and premature infants Am J Obstet Gynecol 1972; 112: 298.Google Scholar
  14. [14]
    Kenny, J. D., Corbet, A. J., Adams, J. M. et al. Hyaline membrane disease and acidosis at birth in twins. Obstet Gynecol 1977; 50: 710.Google Scholar
  15. [15]
    Quirk, J. G., Raker, R., Petrie, R. H., et al. The role of glucocorticoids, unstressful labour and atraumatic delivery in the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1979; 134: 768.Google Scholar
  16. [16]
    Bergman, B. and Hedner, T. Antepartum administration of terbutaline and incidence of hyaline membrane disease in preterm infants. Acta Obstet Gynecol Scand 1978; 57: 217.CrossRefGoogle Scholar
  17. [17]
    Schutte, M. F., Treffers, P. E. and Kopper, J. G. Threatened preterm labour: the influence of time factors on the incidence of respiratory distress syndrome. Obstet Gynecol 1983; 62: 287.CrossRefGoogle Scholar
  18. [18]
    Ekelund, L., Burgoyne, R. and Enhorning, G. Pulmonary surfactant release in fetal rabbits: immediate and delayed response to terbutaline. Am J Obstet Gynecol 1983; 147: 437.Google Scholar
  19. [19]
    Cosmi, E. V. Role of betasympathomimetics and aminophylline on fetal lung maturation. In: Vignali, M., Cosmi, E. V. and Luerti, M., eds. Diagnosis and Treatment of Fetal Lung Immaturity, Milan: Masson Italia, 1985; 127.Google Scholar
  20. [20]
    White, E., Shy, K. K. and Dalin, J. R. An investigation of the relationship between caesarean section birth and respiratory distress syndrome of the newborn. Am J. Epidemiol 1985; 121: 651.CrossRefGoogle Scholar
  21. [21]
    Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981; 141: 276.Google Scholar
  22. [22]
    Depp, R., Boehm, J. J., Nosek, J. A., Dooley, S. L. and Hobart, J. M. Antenatal corticosteroids to prevent neonatal respiratory distress syndrome: risk versus benefit consideration. Am J Obstet Gynecol 1980; 137: 338.Google Scholar
  23. [23]
    Cox, D. R. Analysis of Binary Data, London: Methuen, 1970; 18.Google Scholar
  24. [24]
    Caspi, E., Schreyer, P., Weinraub, Z., Lifshitz, Y. and Goldberg, M. Dexamethasone for prevention of respiratory distress syndrome: multiple perinatal factors. Obstet Gynecol 1981; 57: 41.Google Scholar
  25. [25]
    Procianoy, R. S., Garcia-Prats, J. A., James, M. A., et al. Hyaline membrane disease and intraventricular haemorrhage in small for gestational age infants. Arch Dis Child 1980; 55: 502.CrossRefGoogle Scholar
  26. [26]
    Perelman, R. H. and Farrell, P. M. Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease. Pediatrics 1982; 70: 570.Google Scholar
  27. [27]
    Liggins, G. C. and Howie, R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515.Google Scholar

Copyright information

© Macmillan Publishers Limited 1991

Authors and Affiliations

  • Massimo Luerti
  • Giulio Bevilacqua
  • Alberto Agarossi
  • Maurizio Rocchetti

There are no affiliations available

Personalised recommendations